Another study disclosed that the CD21lo/neg B cell subset that express low levels or lack surface CD21 was increased in SSc patients with ILD compared to those without ILD and healthy subjects, but frequencies of CD21lo/neg B cells did not differ between patients with diffuse vs. those with limited disease (24). Here, CR2 is linked to systemic sclerosis.